Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2505 EUR | -3.28% | -1.76% | +8.91% |
Business Summary
Number of employees: 13
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 10-04-30 | |
Heike Balzer
DFI | Director of Finance/CFO | - | 99-12-31 |
Ewelina Staniuk
IRC | Investor Relations Contact | - | 17-12-31 |
Karen Ophoff
HRO | Human Resources Officer | - | 00-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 20-06-29 | |
Chairman | 76 | 16-08-31 | |
Susan Coles
BRD | Director/Board Member | 58 | 21-06-23 |
Martine van Vugt
BRD | Director/Board Member | 71 | 21-06-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,317,193 | 1,721,941 ( 32.38 %) | 14,979 ( 0.2817 %) | 32.38 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.91% | 7.87M | |
+4.09% | 43.84B | |
+46.96% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- ALTME Stock
- Company TME Pharma N.V.